The role of bisphosphonates in breast cancer: Actions of bisphosphonates in animal models of breast cancer
The skeleton is the most common site of breast cancer metastases. These bone metastases are usually osteolytic and cause significant morbidity. Bisphosphonates, potent inhibitors of bone resorption, reduce skeletal morbidity in breast cancer patients with bone metastases. Animal studies with bisphos...
Uloženo v:
| Vydáno v: | Breast Cancer Res |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2001
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC138714/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11879558/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/bcr415 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|